Gene · 644079
Papers2,404
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,404
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of furmonertinib on the pharmacokinetics of rivaroxaban or apixaban in vivo. | J Chromatogr B Analyt Technol Biomed Life Sci | 2025 | 39675152 | PubTator, text mining | PubMed |
| RAPID-CRISPR: highly sensitive diagnostic assay for detection of PML::RARA isoforms in acute promyelocytic leukemia. | Blood Adv | 2025 | 39622167 | PubTator, text mining | PubMed |
| Distribution Characteristics and Impacting Factors of Drug CYP Enzymes and Transporters in the Gastrointestinal Tract of Chinese Healthy Subjects. | Clin Pharmacol Ther | 2025 | 39582241 | PubTator, text mining | PubMed |
| Interaction of Phyllanthus amarus extract and its lignans with human xenobiotic receptors, drug metabolizing enzymes and drug transporters. | J Ethnopharmacol | 2025 | 39571700 | PubTator, text mining | PubMed |
| Dietary protein intake and the tubular handling of indoxyl sulfate. | Nephrol Dial Transplant | 2025 | 39354683 | PubTator, text mining | PubMed |
| Studies on pharmacokinetic properties and intestinal absorption mechanism of sanguinarine chloride: in vivo and in situ. | Toxicol Mech Methods | 2025 | 39087424 | PubTator, text mining | PubMed |
| Coptisine enhances the sensitivity of chemoresistant breast cancer cells by inhibiting the function and expression of ABC transporters. | Front Pharmacol | 2024 | 39691399 | PubTator, text mining | PubMed |
| Endogenous plasma riboflavin is not a viable BCRP biomarker in human. | Clin Transl Sci | 2024 | 39688426 | PubTator, text mining | PubMed |
| In vitro safety evaluation of dopamine D3R antagonist, R-VK4-116, as a potential medication for the treatment of opioid use disorder. | PLoS One | 2024 | 39680602 | PubTator, text mining | PubMed |
| Modulation of Multispecific Transporters by Uncaria tomentosa Extract and Its Major Phytoconstituents. | Pharmaceutics | 2024 | 39598486 | PubTator, text mining | PubMed |
| Aprocitentan: a new emerging prospect in the pharmacotherapy of hypertension. | Blood Press | 2024 | 39520722 | PubTator, text mining | PubMed |
| Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians. | Clin Pharmacokinet | 2024 | 39509076 | PubTator, text mining | PubMed |
| Impact of Simultaneous Presence of Multiple PML-RARA Isoforms on Phenotype in Patients with Acute Promyelocytic Leukaemia. | J Coll Physicians Surg Pak | 2024 | 39491447 | PubTator, text mining | PubMed |
| Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition. | Arch Pharm Res | 2024 | 39482441 | PubTator, text mining | PubMed |
| Preclinical assessment of the PI3Kα selective inhibitor inavolisib and prediction of its pharmacokinetics and efficacious dose in human. | Xenobiotica | 2024 | 39387185 | PubTator, text mining | PubMed |
| Modulation of Multidrug Resistance Transporters by Food Components and Dietary Supplements: Implications for Cancer Therapy Efficacy and Safety. | Curr Issues Mol Biol | 2024 | 39329928 | PubTator, text mining | PubMed |
| Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport. | Toxicol Appl Pharmacol | 2024 | 39326791 | PubTator, text mining | PubMed |
| IL-17A activates JAK/STAT signaling to affect drug metabolizing enzymes and transporters in HepaRG cells. | Mol Immunol | 2024 | 39305848 | PubTator, text mining | PubMed |
| Short Communication: Novel Di- and Triselenoesters as Effective Therapeutic Agents Inhibiting Multidrug Resistance Proteins in Breast Cancer Cells. | Int J Mol Sci | 2024 | 39273679 | PubTator, text mining | PubMed |
| Lack of effects of polystyrene micro- and nanoplastics on activity and expression of human drug transporters. | Environ Toxicol Pharmacol | 2024 | 39260711 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/644079/papers?page=6